This inventor holds 1 USPTO granted patent. Top assignees: Biogaia Ab, The University of Texas System. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Baokun He: Innovator in Immunology
Introduction
Baokun He is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of immunology, particularly in the treatment of diseases associated with Treg deficiency.
Latest Patents
Baokun He holds a patent for the "Use of inosine for the treatment of T-reg deficiency." This invention provides a method for using inosine to treat diseases related to Treg deficiency or dysfunction, such as immune dysregulation and the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). The patent outlines that inosine can be administered in the form of a bacterial strain capable of stimulating its production. Additionally, it includes methods for stimulating inosine production in subjects and selecting appropriate bacterial strains.
Career Highlights
Throughout his career, Baokun He has worked with reputable organizations, including Biogaia AB and the University of Texas System. His work has focused on advancing the understanding and treatment of immune-related conditions.
Collaborations
Baokun He has collaborated with esteemed colleagues such as Stefan Roos and Yuying Liu, contributing to the advancement of research in his field.
Conclusion
Baokun He is a distinguished inventor whose work in immunology has the potential to impact the treatment of Treg deficiency-related diseases significantly. His innovative approach to using inosine showcases the importance of research and development in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile